| PACKAGING TYPE: | 1x30 C-box |
| COMPOSITION: | Lenvatinib Mesylate Ip 4.90mg Eq. To Lenvatinib 4mg Capsule |
| FORMULATION: | Capsule |
| Description: | LEVANIB-4 Capsule contains Lenvatinib 4 mg, an oral targeted therapy (tyrosine kinase inhibitor) used in the treatment of various cancers. It works by inhibiting multiple receptor tyrosine kinases involved in tumor growth, angiogenesis, and cancer progression. Lenvatinib is commonly prescribed for thyroid cancer, hepatocellular carcinoma (liver cancer), renal cell carcinoma, and endometrial cancer. This medication helps slow tumor growth and spread, improving clinical outcomes in cancer patients. |
| Side Effects: | Hypertension (high blood pressure) Fatigue Diarrhea Decreased appetite Weight loss Nausea or vomiting Rare: Liver or kidney function abnormalities |
| How to Use: | Take the capsule as prescribed by an oncologist Usually taken once daily Swallow whole with water; do not crush or chew Can be taken with or without food Follow exact dosing schedule as directed |
| Precaution: | Use only under strict medical supervision Monitor blood pressure regularly Regular liver and kidney function tests required Not recommended during pregnancy or breastfeeding Use effective contraception during treatment Inform doctor about all medications |
| Product Benefits: | Targeted anticancer therapy Inhibits tumor growth and angiogenesis Effective in multiple cancer types Oral administration for patient convenience Helps improve progression-free survival Widely used in oncology treatment protocols |
Frequently Asked Questions
It is used to treat cancers such as thyroid cancer, liver cancer, kidney cancer, and endometrial cancer.
It blocks specific proteins that promote tumor growth and blood vessel formation.
Yes, regular monitoring of blood pressure and organ function is essential.










